Keywords: آدنوکارسینوم پانکراس داکتال; Early Detection; IPMN; Circulating Tumor Cells; Pancreatic Cancer; CEC; circulating epithelial cell; DAPI; 4â²,6-diamidino-2-phenylindole; GEDI; geometrically enhanced differential immunocapture; IPMN; intraductal papillary mucinous neoplasm; PDAC; pancr
مقالات ISI آدنوکارسینوم پانکراس داکتال (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آدنوکارسینوم پانکراس داکتال; Intrahepatic cholangiocarcinoma; Pancreatic ductal adenocarcinoma; S100P; pVHL; MUC5AC; CK17; IMP3; Maspin
Keywords: آدنوکارسینوم پانکراس داکتال; ARF; alternative reading frame; αSMA; alpha smooth muscle actin; CDK; cyclin-dependent kinase; DDR; DNA damage response; ECM; extracellular matrix; EMT; epithelial mesenchymal transition; FGF; fibroblast growth factor; HDAC; histone deacetylase; HIC1; hy
Keywords: آدنوکارسینوم پانکراس داکتال; CSC; cancer stem cells; PDAC; pancreatic ductal adenocarcinoma; TSC; tissue stem cells; Insulin; Diabetes; β cells; KRAS; LGR5; Nanog;
Keywords: آدنوکارسینوم پانکراس داکتال; COX-2; cyclooxygenase-2; CTLs; Cytotoxic T Lymphocytes; DCs; dendritic cells; ECM; extracellular matrix; EGF; epidermal growth factor; FAK; focal adhesion kinase; FAP-α; fibroblast activation protein-α; FGF; fibroblast growth factor; HSCs; hepatic stell
Keywords: آدنوکارسینوم پانکراس داکتال; PDAC; Pancreatic ductal adenocarcinoma; CRC; Colorectal cancer; EMT; Epithelial-mesenchymal transition; MUC1-CT; MUC1 cytoplasmic tail; N-t; Amino-terminal; C-t; Carboxy-terminal; PTS; Proline Threonine Serine; 5-FU; 5-fluoro-uracile; ROS; Reactive oxyg
Keywords: آدنوکارسینوم پانکراس داکتال; PMPMEase; Pancreatic cancer; Polyisoprenylation; Prenylation; Polyisoprenylated cysteinyl amides; PCAIs; EGFR; epidermal growth factor receptor; FTS; S-t, t farnesylthiosalicylic acid (Salirasib); FTSA; S-t, t farnesylthiosalicylamide; NT; normal tissue;
Keywords: آدنوکارسینوم پانکراس داکتال; Pancreatic Cancer; Pathogenesis; Mouse Model; Signal Transduction; ADM; acinar-to-ductal metaplasia; COX; cyclooxygenase; DAPI; 4â²,6-diamidino-2-phenylindole; DCLK1; doublecortin-like kinase 1; EGFR; epidermal growth factor receptor; IF; immunofluoresce
Keywords: آدنوکارسینوم پانکراس داکتال; PDAC; Pancreatic ductal adenocarcinoma; CT; computerized tomography; EUS; endoscopic ultrasound; ERCP; endoscopic retrograde cholangiopancreatography; CA; Carbohydrate antigen/cancer antigen; CEA; carcinoembryonic antigen; EGTM; European Group on Tumor Ma
Keywords: آدنوکارسینوم پانکراس داکتال; Cancer models; Pancreatic ductal adenocarcinoma; Tumor microenvironment; Inflammation; Target validation; Therapeutic strategies;
Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas
Keywords: آدنوکارسینوم پانکراس داکتال; IVIM; Intravoxel incoherent motion; ADC; Apparent diffusion coefficient; Dt; True molecular diffusion; f; Perfusion fraction; Dp; Perfusion-related diffusion; DDC; Distributed diffusion coefficient; AUC; Area under the curve; pNET; Pancreatic neuroendocri
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
Keywords: آدنوکارسینوم پانکراس داکتال; Immune Response Heterogeneity; Immune Therapy; Antitumor Immunity; Pancreatic Cancer Treatment; CAR; chimeric antigen receptor; CARTmeso; mesothelin-specific CAR T cells; FDG; 18F-2-fluoro-2-deoxy-D-glucose; IL; interleukin; MAV; metabolically active volu
High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma
Keywords: آدنوکارسینوم پانکراس داکتال; G-protein-coupled receptor kinase 3; Pancreatic ductal adenocarcinoma; Prognosis; Immunohistochemistry; Tissue microarray;
Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression
Keywords: آدنوکارسینوم پانکراس داکتال; miR-637; Pancreatic ductal adenocarcinoma; Akt1; Tumor-suppressor; Apoptosis;
Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma
Keywords: آدنوکارسینوم پانکراس داکتال; CRP/Albumin ratio; Pancreatic ductal adenocarcinoma; Postoperative marker;
Retrospective cohort of pancreatic and Vater ampullary adenocarcinoma from a reference center in Mexico
Keywords: آدنوکارسینوم پانکراس داکتال; Adenocarcinoma; Pancreatic ductal adenocarcinoma; Ampulla of Vater adenocarcinoma; Periampullary tumors; Retrospective cohort; Pancreaticoduodenectomy;
The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis
Keywords: آدنوکارسینوم پانکراس داکتال; Pancreatic ductal adenocarcinoma; Programmed cell death ligand 1; Prognosis; Meta-analysis;
A novel prognostic biomarker for pancreatic ductal adenocarcinoma: hsa_circ_0001649
Keywords: آدنوکارسینوم پانکراس داکتال; ATCC; American Type Culture Collection; CCK-8; cell counting kit-8; HPDE; human pancreatic duct epithelial; ceRNA; competing endogenous RNA; circRNAs; circular RNAs; PBS; phosphate buffered saline; PDAC; pancreatic ductal adenocarcinoma; PI; propidium iod
Ferroptosis is a lysosomal cell death process
Keywords: آدنوکارسینوم پانکراس داکتال; Ferroptosis; STAT3; Lysosomal cell death; Autophagy; Cathepsin; PDAC; pancreatic ductal adenocarcinoma; STAT3; signal transducer and activator of transcription 3; GPX4; glutathione peroxidase 4; NRF2; nuclear factor erythroid 2-related factor 2; Q-PCR; qu
SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis
Keywords: آدنوکارسینوم پانکراس داکتال; SALL4; Pancreatic ductal adenocarcinoma; Metastasis; FoxM1; Peroxiredoxin III;
Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis
Keywords: آدنوکارسینوم پانکراس داکتال; ATCC; American type culture collection; CCK-8; cell counting kit-8; HPDE; human pancreatic duct epithelial; IHC; immunohistochemistry; lncRNA; long non-coding RNA; PBS; phosphate-buffered saline; PDAC; pancreatic ductal adenocarcinoma; PI; propidium iodid
Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling
Keywords: آدنوکارسینوم پانکراس داکتال; Pancreatic ductal adenocarcinoma; Integrin β1; Gemcitabine; Cdc42; PI3K p110β signaling;
The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies
Keywords: آدنوکارسینوم پانکراس داکتال; LncRNA AFAP1-AS1; Cancer; Prognostic; Clinicopathological, meta-analysis; OS; overall survival; PFS; progression-free survival; DFS; disease-free survival; RFS; relapse free survival; CP; clinical parameters; NSCLC; non-small cell lung cancer; PDAC; pancr
Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis
Keywords: آدنوکارسینوم پانکراس داکتال; Pancreatic ductal adenocarcinoma; Neutrophils; CD177; Prognosis; Inflammation; RNA-Seq;
High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5
Keywords: آدنوکارسینوم پانکراس داکتال; Glypican-5; miR-4295; Pancreatic ductal adenocarcinoma; Wnt;
Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5
Keywords: آدنوکارسینوم پانکراس داکتال; KLF9; Pancreatic ductal adenocarcinoma; Frizzled-5; Proliferation;
Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma
Keywords: آدنوکارسینوم پانکراس داکتال; Rb; retinoblastoma-associated protein-1; CDK4/6; cyclin-dependent kinases 4 and 6; MGMT; O6-methylguanine-DNA-alkyltranferase; FEN1; flap endonuclease-1; PDAC; pancreatic ductal adenocarcinoma; DFS; disease-free survival; RFS; relapse-free survival; OS; o
La caractérisation moléculaire définit plusieurs sous-types d'adénocarcinome canalaire du pancréas
Keywords: آدنوکارسینوم پانکراس داکتال; Adénocarcinome pancréatique; Classifications moléculaires; Analyses à haut débit Génomique; Trancriptomique; Métabolomique; Pancreatic ductal adenocarcinoma; Molecular classification; High throughput analyses; Genomic; Transcriptomic; Metabolomic;
MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma
Keywords: آدنوکارسینوم پانکراس داکتال; miR-7-5p; Tumor suppressor; SOX18; Pancreatic ductal adenocarcinoma;
Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC
Keywords: آدنوکارسینوم پانکراس داکتال; KLK10; Metastasis; EMT; Pancreatic ductal adenocarcinoma;
Mutations in Mitochondrial DNA From Pancreatic Ductal Adenocarcinomas Associate With Survival Times of Patients and Accumulate as Tumors Progress
Keywords: آدنوکارسینوم پانکراس داکتال; Pancreatic Cancer; Genomics; Genetics; CR; control region; HF; heteroplasmy fraction; MCN; mitochondrial copy number; mtDNA; mitochondrial DNA; mtSNV; mitochondrial somatic nuclear variant; PDAC; pancreatic ductal adenocarcinoma;
MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes
Keywords: آدنوکارسینوم پانکراس داکتال; miR-17-5p; RBL2; E2F4; Cell cycle; Pancreatic cancer; CRF; Chromatin remodeling factor; DP; Dimerization partner; HDACs; Histone deacetylases; MuvB; Multivulva class B; PDAC; Pancreatic ductal adenocarcinoma; RBL2; Retinoblastoma-like protein2;
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Keywords: آدنوکارسینوم پانکراس داکتال; Pancreatic ductal adenocarcinoma; Borderline resectable; Anatomical definition; Biological definition; Conditional definition;
Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer
Keywords: آدنوکارسینوم پانکراس داکتال; 3D Organoids; Pancreas; Adenocarcinoma; Personalized Medicine; 3D; 3-dimensional; GEMMs; genetically engineered mouse models; PanIN; pancreatic intraepithelial neoplasia; PDAC; pancreatic ductal adenocarcinoma; PDX; patient-derived tumor xenografts;
Identification and functional analysis of heterogeneous FOXP3+ Treg cell subpopulations in human pancreatic ductal adenocarcinoma
Keywords: آدنوکارسینوم پانکراس داکتال; Pancreatic ductal adenocarcinoma; Regulatory T cells; Heterogeneity; Tumor draining lymph nodes;
DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts
Keywords: آدنوکارسینوم پانکراس داکتال; αSMA; α smooth muscle actin; ANGPT/TIE; angiopoietin/tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domains; DCE-MRI; dynamic contrast-enhanced magnetic resonance imaging; FOV; field of view; HE; hematoxylin and eosin; HF; hyp
Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine
Keywords: آدنوکارسینوم پانکراس داکتال; AUC; area under the curve; CI; confidence interval; PDAC; pancreatic ductal adenocarcinoma; VOC; volatile organic compound;
Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer
Keywords: آدنوکارسینوم پانکراس داکتال; Lipoxin A4; Pancreatic stellate cells; Cancer-associated fibroblasts; Pancreatic cancer; Tumor stroma; Human pancreatic stellate cell; hPSC; Cancer-associated fibroblast; CAF; Pancreatic ductal adenocarcinoma; PDAC; Lipoxin A4; LXA4; Lipoxin B4; LXB4; Tra
Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer?
Keywords: آدنوکارسینوم پانکراس داکتال; Pancreatic ductal adenocarcinoma; Patient Derived Xenografts; Biomarkers; Drug discovery; Personalized medicine;
PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma
Keywords: آدنوکارسینوم پانکراس داکتال; 3T3; NIH3T3 mouse fibroblast cells; CAF; cancer-associated fibroblast; CAFM; CAF-conditioned media; CHX; cyclohexamide; DMSO; dimethyl sulfoxide; EpM; epithelial-conditioned media; IgG; immunoglobulin G; IP; immunoprecipitate; MOE; MTSS1 overexpression; M
Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice
Keywords: آدنوکارسینوم پانکراس داکتال; Tumor Progression; Immune Cell Migration; Anti-tumor Immune Response; Infiltration; ChIP; chromatin immunoprecipitation; CM; conditioned medium; HUVEC; human umbilical vein endothelial cell; IHC; immunohistochemistry; MLC; monocyte lineage cell; MVD; micr
Cancer history: A predictor of IPMN subtype and dysplastic status?
Keywords: آدنوکارسینوم پانکراس داکتال; IPMN; Family history; Pancreatic ductal adenocarcinoma; Past medical history; Malignant progression;
Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer
Keywords: آدنوکارسینوم پانکراس داکتال; CCK Receptor; Gene Therapy; Gastrin; Nanotechnology; Orthotopic; CCK; cholecystokinin; Ex/Em; maximal excitation and emission wavelengths; Ga-10; gastrin 10 peptide; mRNA; messenger RNA; MW; molecular weight; N/P; ratio of “amines” of poly (L-lysine)
ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice
Keywords: آدنوکارسینوم پانکراس داکتال; Oncogene; Pancreatic Cancer; Transcriptional Regulator; Tumorigenesis; 2D; 2-dimensional; 3D; 3-dimensional; ATP; adenosine triphosphate; IPMN; intraductal papillary mucinous neoplasm; MCN; mucinous cystic neoplasm; PI3K; phosphatidylinositol 3-kinase; Pa
Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy
Keywords: آدنوکارسینوم پانکراس داکتال; PTEN; Kras; Cholangiocarcinoma; Pancreatic cancer; ICC; Intrahepatic cholangiocarcinoma; HCC; hepatocellular carcinoma; ECC; extrahepatic bile duct carcinoma; PanIN; premalignant pancreatic intraepithelial neoplasms; PDAC; pancreatic ductal adenocarcinoma
Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment
Keywords: آدنوکارسینوم پانکراس داکتال; FNB; fine-needle biopsy; NGS; next-generation sequencing; PDA; pancreatic ductal adenocarcinoma; ROSE; rapid onsite evaluation;
Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1
Keywords: آدنوکارسینوم پانکراس داکتال; PHF5A; ERK; Pancreatic Carcinogenesis; Nicotine Receptor Signaling; AF; autofluorescence; ALDH; aldehyde dehydrogenase; AP-1; Activator Protein-1; C-CSE; commercial CSE; ChIP; chromatin immunoprecipitation; CHRNA7; cholinergic receptor nicotinic alpha 7
Silencing circular RNA hsa_circ_0000977 suppresses pancreatic ductal adenocarcinoma progression by stimulating miR-874-3p and inhibiting PLK1 expression
Keywords: آدنوکارسینوم پانکراس داکتال; hsa_circ_0000977; miR-874-3p; ceRNAs; PLK1; PDAC proliferation; CircRNAs; Circular RNAs; RBP; RNA-binding protein; miRNA; microRNA; PLK1; Polo like kinase 1; PDAC; pancreatic ductal adenocarcinoma; ceRNAs; Competing endogenous RNAs; siRNA; small interferi
Efficacy of EUS-guided and ERCP-guided biliary drainage for malignant biliary obstruction: prospective randomized controlled study
Keywords: آدنوکارسینوم پانکراس داکتال; ERCP-BD; ERCP-guided biliary drainage; EUS-BD; EUS-guided biliary drainage; PDAC; pancreatic ductal adenocarcinoma;
PKM2, a potential target for regulating cancer
Keywords: آدنوکارسینوم پانکراس داکتال; PK; pyruvate kinase; HCC; hepatocellular carcinoma; FBP; fructose 1,6-bisphosphate; SAICAR; Succinyl-5-aminoimidazole-4-carboxamide-1-ribose-50-phosphate; hnRNPs; heterogeneous nuclear ribonucleoproteins; PTB; polypyrimidine tract-binding protein; NEK2; n